64
47
Growth Score 64 in past quarter
-21 pts
Heat Score 47 in past quarter
-22 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
714272
CannaLean is an R&D company developing CBD based solutions to benefit millions of patients suffering from Dyslipidemia.
- Ofer Alshech: CFOPast Role: Founder Institute, Startup Mentor
- David Bassa: CEO
About the Company
CannaLean is an R&D company developing CBD based solutions to benefit millions of patients suffering from Dyslipidemia. The company is committed to the research and development of a novel proprietary formulation of Cannabidiol (CBD) and Chitosan that will potentially benefit millions of patients suffering from Dyslipidemia.
CannaLean's
preliminary results show the effect of the formulation of cholesterol and triglyceride reduction. It uses a synthetic form of CBD, a non-psychotropic component of cannabis, with chitosan, a biocompatible, non-toxic, and non-immunogenic compound that enhances the potential of CBD to reduce lipid blood levels.
CannaLean was founded in 2017 and is headquartered in Bene Beraq, Israel.